Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: A review of the literature

Journal of Clinical Pharmacology

Volumn 43, Issue 2, 2003, Pages 111-117

  Gammaitoni, Arnold R ^a   Alvarez, Nancy A ^b   Galer, Bradley S ^b  

^a Endo Pharmaceuticals   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CAPSAICIN; CELECOXIB; CLONIDINE; DIAZEPAM; EMLA; GABAPENTIN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; IBUPROFEN; LIDOCAINE; METAXALONE; METHADONE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; ROFECOXIB; SERTRALINE; TIZANIDINE; TRAMADOL;

ADULT; ANALGESIA; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE DEFECT; COMPLEX REGIONAL PAIN SYNDROME; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG ABSORPTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MERALGIA PARESTHETICA; MYOFASCIAL PAIN; NAUSEA; NEURALGIA; NEUROPATHY; NEUROTOXICITY; NOCICEPTION; NORMAL HUMAN; POSTHERPETIC NEURALGIA; POSTOPERATIVE PAIN; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEDATION; SENSATION; SIDE EFFECT; SKIN EDEMA; SKIN MANIFESTATION; SWEATING; VERTIGO;

ADMINISTRATION, CUTANEOUS; AGED; ANALGESIA; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CLINICAL TRIALS; ERYTHEMA; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED;

EID: 0037303831     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270002239817     Document Type: Review

References (32)

1. Argoff CE: New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain 2000;16:S62-S66.
2. Galer BS, Rowbotham MC, Perander J, Friedman E: Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533-538.
3. Bennett GJ: An animal model of neuropathic pain: a review. Muscle Nerve 1993;16:1040-1048.
4. Devor M: Neuropathic pain and injured nerve: peripheral mechanisms. Br Med Bull 1991;47:619-630.
5. Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-1964.
6. Watson CPN: Topical local anesthetics for neuropathic pain, in: Hansson PT, Fields HL, Hill RG, Marchettini P (eds.), Neuropathic Pain: Pathophysiology and Treatment. Progress in Pain Research and Management, vol. 21. Seattle: IASP Press, 2001;215-221.
7. Black JA, Dib-Hajj S, Cummins TR, Okuse K, Baker M, Wood JN, et al: Sodium channels as therapeutic targets in neuropathic pain, in: Hansson PT, Fields HL, Hill RG, Marchettini P (eds.), Neuropathic Pain: Pathophysiology and Treatment. Progress in Pain Research and Management, vol. 21. Seattle: IASP Press, 2001;19-36.
8. Comer AM, Lamb HM: Lidocaine patch 5%. Drugs 2000;59:245-249.
9. Rowbotham MC, Reisner-Keller LA, Fields HL: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991;41:1024-1028.
10. Rowbotham MC, Davies PS, Fields HL: Topical lidocaine gel reduces pain in post-herpetic neuralgia. Ann Neurol 1995;37:246-228.
11. Galer BS: Topical medications, in: Loeser JD (ed.), Bonica's Management of Pain. Philadelphia: Lippincott, Williams & Wilkins, 2001;1736-1741.
12. Endo Pharmaceuticals, Inc. Lidoderm package insert. Chadds Ford, PA, 2001.
13. Rowbotham MC, Davies PS, Verkempinck C, Galer BS: Lidocaine patch: double-blind controlled study of new treatment method for postherpetic neuralgia. Pain 1996;65:39-44.
14. Galer BS: Lidocaine patch 5%: a viewpoint [guest commentary]. Drugs 2000;59:250-251.
15. Galer BS, Gammaitoni AR: Over 7 years of consistent neuropathic pain relief in geriatric patients. Arch Intern Med; in press.
16. Argoff CE: A review of the use of topical analgesics for myofascial pain. Curr Pain Headache Rep 2002;6:375-378.
17. DeBenedittis G, Lorenzetti A: Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 1996;65:45-61.
18. Capsaicin Study Group: Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992;15:159-165.
19. Chad DA, Aronin N, Lundstrom R, et al: Does capsaicin relieve the pain of diabetic neuropathy? Pain 1990;2:387-388.
20. Low PA, Opfer-Gehrking TL, Dyck PJ, et al: Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 1995;62:163-168.
21. Mannion RJ, Doubell TP, Coggeshall RE, Woolf CJ: Collateral sprouting of uninjured primary afferent A-fibers into the superficial dorsal horn of the adult rat spinal cord after topical capsaicin treatment to the sciatic nerve. J Neurosci 1996;16:5189-5195.
22. Nolano M, Simone DA, Wendelschafer-Crabb G, et al: Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 1999;81:135-145.
23. Davis KD, Treede RD, Raja SN, et al: Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991;47:309-317.
24. Galer BS, Devers A: The treatment of neuropathic pain with topical clonidine, a pilot study [abstract]. Paper presented at the 17th annual scientific meeting of the American Pain Society, San Diego, November 5-8, 1998.
25. Data on file. Endo Pharmaceuticals, Inc., Chadds Ford, PA, 2002.
26. Gammaitoni AR, Alvarez NA, Galer BS: Evaluation of the safety and tolerability of 24-hour application of the lidocaine patch 5%. Am J Health Sys Pharm; in press.
27. Gammaitoni AR, Davis MW: Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002;36:236-240.
28. Katz NP, Gammaitoni AR, Davis MW, Dworkin RH: Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial. Pain Med; in press.
29. Devers A, Galer BS: Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000;16:205-208.
30. Argoff CE: Lidocaine patch 5% and the management of chronic pain. South Med J; in press.
31. Lipman AG, Dalpiaz AS, Lordon SP: Topical lidocaine patch therapy for myofascial pain. Paper presented at the 21st annual scientific meeting of the American Pain Society, Baltimore, March 15, 2002.
32. Hines R, Keaney D, Moskowitz MH, Prakken S: Lidocaine patch 5% is an effective treatment in patients with chronic low back pain. Pain Med; in press.